L'apport technologique en immuno-oncologie: Des concepts fondamentaux au suivi immunologique des patients

S. Chouaib; H. Echchakir; E. Angevin; N. Guerra; K. Kosmatopoulos; A. Caignard; A. Lim; V. Baron; L. Ferradini; F. Mami-Chouaib

L'apport technologique en immuno-oncologie: Des concepts fondamentaux au suivi immunologique des patients

S. Chouaib, H. Echchakir, E. Angevin, N. Guerra, K. Kosmatopoulos, A. Caignard, A. Lim, V. Baron, L. Ferradini, F. Mami-Chouaib

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

1 Citation (Scopus)

Résumé

Over the past decade, cancer immunology has known several advances due to both basic research and new technologies recently developed in this field. This review will illustrate the impact of some new immunological technologies and how the latter resulted in the exploration of new territories in cancer immunology and the emergence of new concepts that allowed to revisit the immunosurveillance concept and permitted to improve the patient monitoring.

Titre traduit de la contribution	Technological advances in immuno-oncology: From fundamental concepts to patient immunological monitoring
langue originale	Français
Pages (de - à)	733-740
Nombre de pages	8
journal	Bulletin du Cancer
Volume	88
Numéro de publication	8
état	Publié - 6 oct. 2001

mots-clés

Cytolytic T lymphocyte
Immunotherapy
Tumor antigen

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{b38a18e679274d51ac75523f7af73a9b,

title = "L'apport technologique en immuno-oncologie: Des concepts fondamentaux au suivi immunologique des patients",

abstract = "Over the past decade, cancer immunology has known several advances due to both basic research and new technologies recently developed in this field. This review will illustrate the impact of some new immunological technologies and how the latter resulted in the exploration of new territories in cancer immunology and the emergence of new concepts that allowed to revisit the immunosurveillance concept and permitted to improve the patient monitoring.",

keywords = "Cytolytic T lymphocyte, Immunotherapy, Tumor antigen",

author = "S. Chouaib and H. Echchakir and E. Angevin and N. Guerra and K. Kosmatopoulos and A. Caignard and A. Lim and V. Baron and L. Ferradini and F. Mami-Chouaib",

year = "2001",

month = oct,

day = "6",

language = "Fran{\c c}ais",

volume = "88",

pages = "733--740",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "8",

}

TY - JOUR

T1 - L'apport technologique en immuno-oncologie

T2 - Des concepts fondamentaux au suivi immunologique des patients

AU - Chouaib, S.

AU - Echchakir, H.

AU - Angevin, E.

AU - Guerra, N.

AU - Kosmatopoulos, K.

AU - Caignard, A.

AU - Lim, A.

AU - Baron, V.

AU - Ferradini, L.

AU - Mami-Chouaib, F.

PY - 2001/10/6

Y1 - 2001/10/6

N2 - Over the past decade, cancer immunology has known several advances due to both basic research and new technologies recently developed in this field. This review will illustrate the impact of some new immunological technologies and how the latter resulted in the exploration of new territories in cancer immunology and the emergence of new concepts that allowed to revisit the immunosurveillance concept and permitted to improve the patient monitoring.

AB - Over the past decade, cancer immunology has known several advances due to both basic research and new technologies recently developed in this field. This review will illustrate the impact of some new immunological technologies and how the latter resulted in the exploration of new territories in cancer immunology and the emergence of new concepts that allowed to revisit the immunosurveillance concept and permitted to improve the patient monitoring.

KW - Cytolytic T lymphocyte

KW - Immunotherapy

KW - Tumor antigen

UR - http://www.scopus.com/inward/record.url?scp=0034836010&partnerID=8YFLogxK

M3 - Article 'review'

C2 - 11578941

AN - SCOPUS:0034836010

SN - 0007-4551

VL - 88

SP - 733

EP - 740

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 8

ER -